BRIVDARQ
LIVE

Serial Number

79359341

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Nov 9, 2022

Add to watchlist:

No watchlists yet
View on USPTO

BRIVDARQ Trademark

Serial Number: 79359341 • Registration: 7064560

BRIVDARQ is a trademark filed by NOVARTIS AG on November 9, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

November 9, 2022

Registration Date

May 30, 2023

Published for Opposition

March 14, 2023

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; [ pharmaceutical preparations acting on the central nervous system; ] pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; * all the foregoing to exclude pharmaceutical preparations for epilepsy treatment *

Filing History

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Dec 16, 2025 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 29, 2025 INPR
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Nov 19, 2024 NURC
AMENDMENT UNDER SECTION 7 - PROCESSED
Oct 11, 2024 A7OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 9, 2024 APRE
TEAS SECTION 7 REQUEST RECEIVED
Apr 4, 2024 ES7R
NOTIFICATION PROCESSED BY IB
Aug 13, 2023 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Jul 20, 2023 FICS
FINAL DISPOSITION PROCESSED
Jul 20, 2023 FIMP
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jul 20, 2023 LIMN
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jun 29, 2023 GPAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 30, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
May 30, 2023 R.PR
LIMITATION OF GOODS RECEIVED FROM IB
Apr 29, 2023 LIMG
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 14, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 14, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 22, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 9, 2023 CNSA
ASSIGNED TO EXAMINER
Feb 8, 2023 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 20, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 20, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 20, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 20, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 20, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 20, 2023 COAR
APPLICATION FILING RECEIPT MAILED
Jan 10, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 6, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 5, 2023 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Dec 30, 2022 SDRC